share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  09/10 06:04

Moomoo AI 已提取核心訊息

On September 9, 2024, Cingulate Inc., a company listed on the Nasdaq Stock Market, announced that it has regained compliance with the Nasdaq's Minimum Bid Price requirement. The Nasdaq Hearings Panel confirmed that Cingulate's common stock met the $1.00 minimum bid price condition necessary for continued listing on the exchange. This follows a previous notification on June 17, 2024, when Cingulate was informed of its non-compliance with the same requirement. The company was granted an exception on August 2, 2024, to meet this requirement by August 23, 2024. Despite regaining compliance, Cingulate will remain under the Nasdaq Panel's discretionary monitoring until May 21, 2025, to ensure ongoing adherence to the exchange's listing rules.
On September 9, 2024, Cingulate Inc., a company listed on the Nasdaq Stock Market, announced that it has regained compliance with the Nasdaq's Minimum Bid Price requirement. The Nasdaq Hearings Panel confirmed that Cingulate's common stock met the $1.00 minimum bid price condition necessary for continued listing on the exchange. This follows a previous notification on June 17, 2024, when Cingulate was informed of its non-compliance with the same requirement. The company was granted an exception on August 2, 2024, to meet this requirement by August 23, 2024. Despite regaining compliance, Cingulate will remain under the Nasdaq Panel's discretionary monitoring until May 21, 2025, to ensure ongoing adherence to the exchange's listing rules.
2024年9月9日,Nasdaq股票市場上市公司Cingulate Inc.宣佈已恢復符合Nasdaq最低買盤價格要求。納斯達克聽證會確認Cingulate的普通股已滿足交易所繼續上市所需的1.00美元最低買盤價格控件。這是在2024年6月17日之前的一次通知之後,Cingulate被告知其不符合相同要求。公司於2024年8月2日獲准在2024年8月23日之前滿足該要求的例外情況。儘管恢復符合規定,但Cingulate將繼續受納斯達克委員會的自由裁量監管,直至2025年5月21日,以確保持續遵守該交易所的上市規則。
2024年9月9日,Nasdaq股票市場上市公司Cingulate Inc.宣佈已恢復符合Nasdaq最低買盤價格要求。納斯達克聽證會確認Cingulate的普通股已滿足交易所繼續上市所需的1.00美元最低買盤價格控件。這是在2024年6月17日之前的一次通知之後,Cingulate被告知其不符合相同要求。公司於2024年8月2日獲准在2024年8月23日之前滿足該要求的例外情況。儘管恢復符合規定,但Cingulate將繼續受納斯達克委員會的自由裁量監管,直至2025年5月21日,以確保持續遵守該交易所的上市規則。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息